CRS 2022 (v22.0 and v22.1)
CRS VERSION 22.1
CRS Version 22.1 was released on July 8, 2022.
Key enhancements included in CRS Version 22.1 are shown below.
- Logic Changes to National GPRA/GPRAMA Report Measures
- GPRA Developmental Measures:
- Added the following GPRA Developmental topic:
- Screening, Brief Intervention, and Referral to Treatment (SBIRT)
- Removed the following GPRA Developmental topic:
- Cancer Screening: Pap Smear Rates
- Added measures to and removed measures from Adult Immunizations topic to align with new Pneumococcal recommendations.
- Updated codes and/or logic in the following measures: Weight Assessment and Counseling for Nutrition and Physical Activity; Appropriate Medication Therapy after a Heart Attack; HIV Quality of Care; Chlamydia Testing; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepine
- Added the following GPRA Developmental topic:
- Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Removed lower age limit for patients with ASCVD. (2) Changed lower age limit to 20 for patients with LDL greater than or equal to (>=) 190. (3) Changed the time period for the denominator exclusion of rhabdomyolysis to be during the report period. (4) Updated the statin allergy denominator exception to statin-associated muscle symptoms or an allergy. (5) Removed the denominator exception for patients with LDL less than (<) 70. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
- Diabetes: Nephropathy Assessment: Added LOINC codes 98979-8, 98980-6 to BGP ESTIMATED GFR LOINC taxonomy.
- Adult Immunizations: Added CVX codes 215, 216 and CPT codes 90671, 90677 to PCV13 definition.
- Cancer Screening: Pap Smear Rates: (1) Changed topic name to Cervical Cancer Screening. (2) Added HPV Primary only in the past five years to the numerator.
- Tobacco Use and Exposure Assessment: Added POV Z71.6 and CPT G9458 to tobacco screening and tobacco user definitions.
- Tobacco Cessation: (1) Added POV Z71.6 and CPT G9458 to tobacco screening and tobacco cessation counseling definition. (2) Added patient education with CPT G9016 to tobacco cessation counseling definition.
- Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Removed lower age limit for patients with ASCVD. (2) Changed lower age limit to 20 for patients with LDL greater than or equal to (>=) 190. (3) Changed the time period for the denominator exclusion of rhabdomyolysis to be during the report period. (4) Updated the statin allergy denominator exception to statin-associated muscle symptoms or an allergy. (5) Removed the denominator exception for patients with LDL less than (<) 70. (6) Updated medication taxonomy BGP PQA STATIN MEDS.
- GPRA Developmental Measures:
- Removed Dental Treatment measure from IPC report.
CRS VERSION 22.0
CRS Version 22.0 was released on March 2, 2022.
Key enhancements included in CRS Version 22.0 are shown below.
- Logic Changes to National GPRA/GPRAMA Report Measures
- GPRA Developmental Measures:
- Removed the following GPRA Developmental topics:
- GPRA Developmental Measures:
-
-
-
- Colorectal Cancer Screening
- Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly
- Updated codes and/or logic in the following measures: Adult Immunizations; Childhood Immunizations; Cancer Screening: Pap Smear Rates; Weight Assessment and Counseling for Nutrition and Physical Activity; Physical Activity Assessment; Appropriate Medication Therapy After a Heart Attack; HIV Screening; HIV Quality of Care; Sexually Transmitted Infection (STI) Screening; Proportion of Days Covered by Medication Therapy; Concurrent Use of Opioids and Benzodiazepines
-
- Statin Therapy to Reduce Cardiovascular Disease Risk in Patients with Diabetes: (1) Added SNOMED subset PXRM BGP IPC HOSPICE to denominator exceptions. (2) Removed POV 412, I24.1, I25.2 from myocardial infarction definition. (3) Removed POV 272.0 from hypercholesterolemia definition. (4) Removed ICD-9 POVs from active liver disease definition. (5) Updated medication taxonomy BGP PQA STATIN MEDS.
- Influenza: Added HCPCS codes Q2034-Q2039 to influenza definition.
- Adult Immunizations: Added HCPCS codes Q2034-Q2039 to influenza definition.
- Cancer Screening: Pap Smear Rates: Added LOINC codes 97156-4, 97157-2 to BGP HPV LOINC CODES taxonomy.
- Colorectal Cancer Screening: Updated denominator age range to 45-75.
- Statin Therapy for the Prevention and Treatment of Cardiovascular Disease: (1) Added SNOMED subset PXRM BGP IPC HOSPICE to denominator exceptions. (2) Removed POV 412, I24.1, I25.2 from myocardial infarction definition. (3) Removed POV 272.0 from hypercholesterolemia definition. (4) Removed ICD-9 POVs from active liver disease definition. (5) Updated medication taxonomy BGP PQA STATIN MEDS.
- HIV Screening: Added LOINC codes 97860-1, 97861-9 to BGP HIV TEST LOINC CODES taxonomy.
-
- Removed the following topics from the Selected Measures Report: Medication Therapy for Persons with Asthma, Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly
- Changed Baseline Year to 2016 from 2010.
- Updated demo patients to include those with an SSN that begins with five zeros.